Latest Media Releases (Page 2) | Finance News Network

Latest Media Releases

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Radiopharm Theranostics - Half Yearly Report and Accounts (ASX:RAD)

To view the report, download the attached PDF.

Radiopharm Theranostics - Dosing begins in Phase 1 Pancreatic Imaging Study of RAD 301 (ASX:RAD)

-- First Pancreatic Cancer participant dosed at the Montefiore Medical Center, New York, USA -- Phase I study of 9 participants is designed to assess the safety and dosimetry of RAD 301 -- A total...read more

Chimeric Therapeutics - Half Yearly Report and Accounts (ASX:CHM)

To view the report, download the attached PDF.

Radiopharm Theranostics - Pilot Study Validates RAD Terbium-161 Radiotherapeutics (ASX:RAD)

-- Publication of first head-to-head data shows superior Therapeutic Index with Tb161 vs Lu177 in 6 metastatic castration-resistant prostate cancer patients. -- This Pilot study validates Radiophar...read more

Immutep - Half Yearly Report and Accounts (ASX:IMM)

To view the report, download the attached PDF.

Next Science - FY23 Annual Result Investor Presentation (ASX:NXS)

To view the presentation, download the attached PDF.

Next Science reports FY23 Result (ASX:NXS)

-- Revenue of US$22.2m, up 89% year-on-year (yoy) with 2H FY23 revenue of US$12.1m in line with 2H FY23 guidance of US$12m-14m provided in October 2023 -- Product Sales of US$22.1m, up 90% yoy refl...read more

Next Science - Appendix 4E / FY23 Financial Statements (ASX:NXS)

To view the appendix, download the attached PDF.

Austco Healthcare HY Dec 23 Results Media Release (ASX:AHC)

Austco Healthcare increases revenues by 11%, further investment in R&D and accelerates direct to market capabilities in Australia Accumulated orders yet to be delivered grow to an...read more

Austco Healthcare Appendix 4D and HY Dec 23 Results (ASX:AHC)

To view the appendix, download the attached PDF.

INOVIQ - Appendix 4D and FY24 Half Year Financial Report (ASX:IIQ)

To view the appendix, download the attached PDF.

INOVIQ detects 19% more breast cancers than leading test (ASX:IIQ)

INOVIQ Limited (ASX:IIQ or INOVIQ) is excited to announce the successful completion of its breast cancer study. In a 2023 clinical validation study (n=483), INOVIQ’s SubB2M/CA15-3 test dete...read more

INOVIQ - Trading Halt (ASX:IIQ)

Description The securities of INOVIQ Ltd (‘IIQ’) will be placed in trading halt at the request of IIQ, pending it releasing an announcement. Unless ASX decides otherwise, the sec...read more

Austco Healthcare enters Term Sheet to acquire Amentco (ASX:AHC)

Highlights Conditional binding term sheet to acquire 100% of the business of Amentco, a healthcare solutions provider and Certified Austco Nurse Call reseller (Acquisition). The A...read more

Radiopharm receives $1.9M advance on FY24 R&D tax incentive (ASX:RAD)

Sydney, Australia – 21 February 2024 – Radiopharm Theranostics Limited (ASX:RAD), a developer of a world class platform of radiopharmaceutical products for both diagnostic and therapeuti...read more

Viewing: 16 - 30 of 200 Previous | Next